S. Klinkenberg

El Khou, Y., Van Lanen, R. H. G. J., Wagner, G. L., Tousseyn, S., De Bruyn, G., Hoeberigs, C. M. C., Wagemans, B. A. J. M., Van Der Leij, C., Klinkenberg, S., Nelissen, J., Kubben, P. L., Schijns, O. E. M. G., Dings, J. T. A., & Rijkers, K. (2026). Pseudoaneurysms as a complication of stereoelectroencephalography: Case series and clinical recommendations. Epilepsia, 67(3), 1193-1205. https://doi.org/10.1002/epi.70048

van Lanen, R. H. G. J., Uher, D., Hoeberigs, C. M. C., Hofman, P. A. M., Santegoeds, R., Wiggins, C., Tse, D. H. Y., Steijvers, E. G. M., Jansen, J. F. A., Drenthen, G. S., Roebroeck, A., Ivanov, D., Poser, B. A., van Kuijk, S. M. J., Hoogland, G., Rijkers, K., Wagner, L. G. L., Widman, G., Beckervordersandforth, J., ... ACE Epilepsy Surgery Group (2026). Value of ultra-high-field MRI in patients with drug-resistant focal epilepsy and negative 3T MRI (EpiUltraStudy): Diagnostic gain of 7T structural analysis. Epilepsia, 67(2), 791-804. https://doi.org/10.1111/epi.18682

van de Wiel, M., Lasscher, V., Altinbas, A., Thijs, R. D., Verhoeven, J., Klinkenberg, S., de Wit, M. C. Y., van Eeghen, A. M., M'Rabet, L., Kasri, N. N., van Dam, L., de Espada, V. M. D. D., Otte, W. M., Braun, K. P. J., & Jansen, F. E. (2025). Cannabidiol as add-on therapy for patients with refractory childhood epilepsy (CBD-uN1que): study protocol for a series of n-of-1 trials. Epilepsia, 66, S433-S433.

Pozzi, S., Sweere, D. J. J., Trucco, F., Johnson, N. E., Sansone, V. A., Workshop Study Group, & Klinkenberg, S. (2025). 284th ENMC International Workshop: Cognitive and behavioral abnormalities in pediatric DM1; what should we measure in preparation for clinical trials? Hoofddorp, The Netherlands, January 24-26 2025. Neuromuscular Disorders, 56-57, Article 106252. https://doi.org/10.1016/j.nmd.2025.106252

Scholten, S., Peterson, J. A. M., Orriëns, L. B., Pastorelli, L., Meola, G., Schoser, B., Braakman, H. M. H., 288th ENMC workshop participants, Klinkenberg, S., & Merkies, I. (2025). 288th ENMC International Workshop. Towards better diagnosing, understanding and treating gastrointestinal symptoms in myotonic dystrophy: extended insights and practical recommendations. 16-18 May 2025, Hoofddorp, the Netherlands. Neuromuscular Disorders, 56-57, Article 106250. https://doi.org/10.1016/j.nmd.2025.106250

Leeuwenberg, K. E., Bruijnes, J. E., Karnebeek, L., Smulders, F., Altena-Rensen, S., Gorissen-Brouwers, C. M. L., Klinkenberg, S., Faber, C. G., Braakman, H., & Mul, K. (2025). The blind men and the elephant: recognising the multisystem symptoms of myotonic dystrophy type 1. Orphanet Journal of Rare Diseases, 20(1), Article 427. https://doi.org/10.1186/s13023-025-03920-z

Sweere, D. J. J., Klinkenberg, S., Vermeulen, R. J., Braakman, H. M. H., & Hendriksen, J. G. M. (2025). Assessment of psychosocial adjustment and reduced initiative in children with myotonic dystrophy type 1: a pilot study on the reliability and clinical utility of a short parent-report questionnaire. European Journal of Paediatric Neurology, 58, 27-33. https://doi.org/10.1016/j.ejpn.2025.07.008

Weerkamp, P. M. M., Voermans, M., Finders, M., Brouwers, A., Collin, P., Klinkenberg, S., & Hendriksen, J. G. M. (2025). Case Report: Home initiation of nocturnal non-invasive ventilation in two adolescents with Duchenne muscular dystrophy and comorbid autism spectrum disorder and ADHD. Frontiers in pediatrics, 13, Article 1525365. https://doi.org/10.3389/fped.2025.1525365

Maas, L., Peeters, C. B. C. M., Hiligsmann, M., vanKuijk, S. M. J., Tousseyn, S., Kellenaers, J., vanMastrigt, G. A. P. G., Vlooswijk, M. C. G., Klinkenberg, S., Wagner, L., Nelissen, J., Schijns, O. E. M. G., Majoie, H. J. M., Rijkers, K., ACE Epilepsy Surgery Group, Dings, J., Hilkman, D., van der Pol, J., van Kranen - Mastenbroek, V., ... van Straaten, I. (2025). A prospective cohort study estimating total pre-surgical healthcare costs before and two-year total societal costs after resective brain surgery, and quality of life of patients with drug-resistant epilepsy undergoing surgery. Journal of Medical Economics, 28(1), 364-376. https://doi.org/10.1080/13696998.2025.2473745

Bennebroek, C. A. M., van Zwol, J., Montauban van Swijndregt, M. C., Porro, G. L., Oostenbrink, R., Dittrich, A. T. M., Pott, J. W., Meijer, L., Janssen, E. J. M., Klinkenberg, S., Bauer, N. J., Notting, I. C., van Genderen, M. M., Tanck, M. W., de Graaf, P., Saeed, P., & Schouten-van Meeteren, A. Y. N. (2025). A Retrospective, Nationwide, Multicenter Study on Diagnosis and Treatment Outcome of Pediatric Optic Pathway/Hypothalamic Gliomas Including Analysis of Risk Factors for Progression After Systemic Anticancer Therapy. Cancers, 17(5), Article 716. https://doi.org/10.3390/cancers17050716